Comparing the effects of metformin versus Pioglitazone administration on 2 hours plasma ghrelin level in patients with type 2 diabetes referred to diabetes clinic of Imam Khomeini Medical Complex during 2011

Vice chancellor for Research, Tehran university of medical science (TUMS)0 sites60 target enrollmentTBD

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: Vice chancellor for Research, Tehran university of medical science (TUMS)
Enrollment: 60
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

8 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Vice chancellor for Research, Tehran university of medical science (TUMS)

Eligibility Criteria

Inclusion Criteria

•Patients with known type 2 diabetes mellitus more than 30 years
•Serum creatinine \< 1\.5 mg/dl in men and \<1\.4 mg/dl in women
•Exclusion criteria:
•Serious cardiovascular diseases
•Advanced renal or hepatic diseases
•Severe diabetes mellitus complications
•Poor compliance

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Phase 1

Comparison of the effect Of Metformin and Pioglitazone on hypertriglyceridemia(Dyslipidemia)Condition 1: Hypertriglyceridemia. Condition 2: Metabolic syndrom.Pure hyperglyceridemiaMetabolic syndromeE78.1E88.81

IRCT20230618058524N1Islamic Azad University68

Completed

Not Applicable

Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified

IRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93

Completed

Phase 3

Comparison of metformin, pioglitazone and vitamin E on nonalcoholic fatty liver diseaseonalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified

IRCT2013071313069N2Vice chancellor for research, Kermanshah University of Medical Sciences93

Completed

Not Applicable

Differential effects of metformin and pioglithazone on hs-CRP in patients with type II DM.diabetes mellitus II.non-insulin-dependent diabetes mellitus

IRCT201109067482N1Qazvin University of Medical Sciences40

Recruiting

Phase 3

empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2

IRCT20220822055771N1Shahre-kord University of Medical Sciences50